Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2026-05-18 @ 8:27 AM
Study NCT ID:
NCT00688558
Status:
COMPLETED
Last Update Posted:
2008-06-03
First Post:
2008-05-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
Sponsor:
Akros Pharma Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AT705-X-03-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Shoji Hoshino, DVM, Vice President, Clinical Development
Old Organization:
Akros Pharma Inc.